您当前的位置:
首页 >
文章列表页 >
To Select Extraction Process of Phenylethanoid Glycosides in Cistanche tubulosa by Method of Orthogonal Multi-index Comprehensive Evaluation
更新时间:2024-09-23
    • To Select Extraction Process of Phenylethanoid Glycosides in Cistanche tubulosa by Method of Orthogonal Multi-index Comprehensive Evaluation

    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 17, Issue 2, Pages: 28-31(2011)
    • DOI:10.13422/j.cnki.syfjx.2011.02.017    

      CLC: R284
    • Published:2011

    移动端阅览

  • MENG Qing-yan1, XIE Ping-fei2, LUO Feng3, et al. To Select Extraction Process of Phenylethanoid Glycosides in Cistanche tubulosa by Method of Orthogonal Multi-index Comprehensive Evaluation[J]. Chinese journal of experimental traditional medical formulae, 2011, 17(2): 28-31. DOI: 10.13422/j.cnki.syfjx.2011.02.017.

  •  
  •  

0

Views

926

下载量

14

CSCD

Alert me when the article has been cited
提交
Tools
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Comprehensive Application of AHP-CRITIC Hybrid Weighting Method, Grey Correlation Analysis and BP-ANN in Optimization of Extraction Process of Qizhi Prescription
Research Progress in Extraction Technology, Structural Characteristics and Pharmacological Activities of Hippophae rhamnoides Polysaccharides
Analysis of Chemical Composition Variations in Plantaginis Semen at Different Frying Time Based on UPLC-Q-TOF/MSE
Advances on Chemical Constituents of Essential Oils from Perillae Folium and Their Pharmacological Effect:A Review

Related Author

MENG Qing-yan
XIE Ping-fei
LUO Feng
ZHOU Zhong-bo
LAN Qun
CHENG Yi
LI Zian
WU Bingyu

Related Institution

Institute of Chinese Materia Medica,China Academy of Chinese Medical Sciences
Medical School, Lijiang Culture and Tourism College
School of Pharmaceutical Science and Technology, Tianjin University
School of Chinese Materia Medica,Tianjin University of Traditional Chinese Medicine
State Key Laboratory of Critical Technology in Innovative Chinese Medicine, Tasly Pharmaceutical Group Co. Ltd.
0